Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Troglitazone in Malignant Liposarcoma
NCT00003058Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jun 1997
- Primary completion
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of troglitazone in Liposarcoma, sponsored by Dana-Farber Cancer Institute. Started Jun 1997; status: completed.
02
Drugs
troglitazone
03
Conditions
Liposarcoma
Beyond the preview
Go deeper on NCT00003058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003058.